Skip to main content
. 2018 Jul 30;13(7):e0201667. doi: 10.1371/journal.pone.0201667

Fig 3. Forest plot depicting the risk ratio of mortality of patients receiving extended or continuous infusion vs intermittent of meropenem.

Fig 3